Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

16.62
Delayed Data
As of Sep 01
 -0.84 / -4.81%
Today’s Change
7.51
Today|||52-Week Range
25.25
+72.23%
Year-to-Date

Today’s Trading

Previous close17.46
Today’s open16.97
Day’s range16.56 - 17.46
Volume1,217,396
Average volume (3 months)1,459,033
Market cap$2.2B
Dividend yield--
Data as of 09/01/2015

Growth & Valuation

Earnings growth (last year)+24.32%
Earnings growth (this year)+20.37%
Earnings growth (next 5 years)--
Revenue growth (last year)+37.47%
P/E ratioNM
Price/Sales15.72
Price/Book53.08

Competitors

 Today’s
change
Today’s
% change
KITEKite Pharma Inc-2.02-3.80%
RDUSRadius Health Inc+0.15+0.25%
MCRBSeres Therapeutics I...-0.36-0.87%
NVAXNovavax Inc-0.26-2.41%
Data as of 09/01/2015

Financials

Next reporting dateNovember 9, 2015
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$75.3M
Annual profit (last year)-$68.4M
Net profit margin-90.76%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts

Partner Offers